Holen Sie sich die Stockscreener-App
12.06
2.12%
0.25
Handel nachbörslich:
11.83
-0.23
-1.91%
Schlusskurs vom Vortag:
$11.81
Offen:
$11.66
24-Stunden-Volumen:
158.30K
Relative Volume:
0.69
Marktkapitalisierung:
$214.26M
Einnahmen:
$114.73M
Nettoeinkommen (Verlust:
$-140.94M
KGV:
-4.3696
EPS:
-2.76
Netto-Cashflow:
$-126.18M
1W Leistung:
-8.08%
1M Leistung:
-19.65%
6M Leistung:
+2.73%
1J Leistung:
+3.59%
1-Tages-Spanne:
$11.41
$12.28
1-Wochen-Bereich:
$11.41
$13.29
52-Wochen-Spanne:
$5.85
$25.35
Outset Medical Inc Stock (OM) Company Profile
Firmenname
Outset Medical Inc
Sektor
Branche
Telefon
669-231-8200
Adresse
3052 ORCHARD DRIVE, SAN JOSE
Vergleichen Sie OM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OM
Outset Medical Inc
|
12.06 | 209.82M | 114.73M | -140.94M | -126.18M | -2.76 |
|
ABT
Abbott Laboratories
|
126.36 | 217.27B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.02 | 146.84B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
356.03 | 135.31B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
92.20 | 115.51B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.39 | 47.84B | 5.88B | 1.34B | 577.90M | 2.3455 |
Outset Medical Inc Stock (OM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-08 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-06-21 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-04-08 | Eingeleitet | BTIG Research | Buy |
| 2024-04-05 | Hochstufung | CL King | Neutral → Buy |
| 2024-01-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-13 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-08-17 | Eingeleitet | CL King | Neutral |
| 2022-11-11 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-07-14 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-08-18 | Eingeleitet | Cowen | Outperform |
| 2021-04-19 | Eingeleitet | Wells Fargo | Overweight |
| 2020-12-16 | Eingeleitet | Oppenheimer | Perform |
| 2020-10-12 | Eingeleitet | Barclays | Overweight |
| 2020-10-12 | Eingeleitet | BofA Securities | Buy |
| 2020-10-12 | Eingeleitet | Goldman | Buy |
| 2020-10-12 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-10-12 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-10-12 | Eingeleitet | Stifel | Buy |
Alle ansehen
Outset Medical Inc Aktie (OM) Neueste Nachrichten
What the charts say about Outset Medical Inc. todayJuly 2025 Movers & Comprehensive Market Scan Insights - newser.com
Earnings To Watch: Outset Medical Inc (OM) Reports Q3 2025 Resul - GuruFocus
Earnings To Watch: Outset Medical Inc (OM) Reports Q3 2025 Result - Yahoo Finance
Using Ichimoku Cloud for Outset Medical Inc. technicalsJuly 2025 Levels & Weekly Momentum Stock Picks - newser.com
Ranking Outset Medical Inc. among high performing stocks via tools2025 Momentum Check & Expert Verified Movement Alerts - newser.com
Will Outset Medical Inc. stock maintain momentum in 2025July 2025 Gainers & Real-Time Buy Zone Alerts - newser.com
Using Python tools to backtest Outset Medical Inc. strategies2025 Fundamental Recap & Daily Volume Surge Trade Alerts - newser.com
Why Outset Medical Inc. stock could outperform in 2025Portfolio Update Summary & Expert Curated Trade Setup Alerts - fcp.pa.gov.br
How sentiment analysis helps forecast Outset Medical Inc.2025 Market Overview & Free Weekly Chart Analysis and Trade Guides - newser.com
Is Outset Medical Inc. reversing from oversold territoryJuly 2025 Intraday Action & Growth Focused Entry Point Reports - newser.com
Is Outset Medical Inc. stock attractive after correctionIPO Watch & Accurate Technical Buy Alerts - newser.com
How to forecast Outset Medical Inc. trends using time seriesJuly 2025 Volume & AI Optimized Trade Strategies - newser.com
How Outset Medical Inc. stock performs in high volatility marketsJuly 2025 PostEarnings & Real-Time Chart Breakout Alerts - newser.com
Identifying reversal signals in Outset Medical Inc.2025 Volume Leaders & Technical Confirmation Trade Alerts - newser.com
Outset Medical Inc. stock volume spike explainedEarnings Trend Report & Capital Efficient Trade Techniques - newser.com
Can Outset Medical Inc. stock deliver surprise earnings beatMarket Movers & AI Enhanced Execution Alerts - newser.com
Outset Medical Announces Significant Research Findings on Insourced Dialysis Outcomes at ASN Kidney Week 2025 - Quiver Quantitative
New Research Demonstrates the Advantages of an Insourced Dialysis Service Line for Acute-Care Facilities Using Outset Medical’s Tablo® Hemodialysis System - The Manila Times
Outset Medical (Nasdaq: OM) cites 1M+ Tablo treatments; 99% goal achievement - Stock Titan
Why Outset Medical Inc. stock appeals to analystsJuly 2025 News Drivers & Growth Focused Entry Point Reports - fcp.pa.gov.br
Outset Medical to Present at the 2025 Stifel Healthcare Conference - The Manila Times
Pattern recognition hints at Outset Medical Inc. upsideMarket Risk Analysis & Low Volatility Stock Suggestions - newser.com
Is Outset Medical Inc. stock positioned for long term growth2025 Fundamental Recap & Technical Buy Zone Confirmations - newser.com
Is Outset Medical Inc. forming a reversal patternWeekly Stock Report & Weekly Breakout Opportunity Watchlist - newser.com
Is Outset Medical Inc a good long term investmentSupport Zone Identification & Top Analyst Picks Available for Free - earlytimes.in
Outset Medical (OM) to Release Quarterly Earnings on Monday - MarketBeat
Outset Medical Inc. stock chart pattern explainedWeekly Stock Report & Weekly Setup with High ROI Potential - newser.com
Finanzdaten der Outset Medical Inc-Aktie (OM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Outset Medical Inc-Aktie (OM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Nash Marc | SVP Operations and R&D |
Aug 15 '25 |
Sale |
12.88 |
243 |
3,130 |
42,898 |
| Brottem John L. | General Counsel |
Aug 15 '25 |
Sale |
12.88 |
383 |
4,933 |
46,883 |
5.21%
1.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):